NY settles FCA claims with KV, Dava Pharma; Baxter gets European nod for flu vax;

@FiercePharma: China's health minister scolds hospitals for profiting off high-priced drugs--Reuters. News | Follow @FiercePharma

> New York's attorney general said KV Pharmaceutical and Dava Pharmaceuticals will pay the state a total of $28 million in separate False Claims Act settlements. More

> Baxter International ($BAX) won European approval for its flu vaccine Vepacel. Report

> Indian pharmaceutical companies are complaining about their country's drug procurement process and are calling for an open tender approach combining supplies of branded and generic drugs. Story

> The U.S. Senate killed a Republican effort to allow employers and insurers to deny coverage for contraceptives and other treatments they object to for religious or moral reasons. Article

> Novartis ($NVS) launched its blood pressure drugs Galvus and Exforge HCT in Ghana. News

> Watson Pharma ($WPI) introduced its version of Abbott Laboratories' ($ABT) hormone drug Prometrium under an agreement with the branded drugmaker. Report

Biotech News

@FierceBiotech: Social media jump-starts stalled patient recruitment efforts. Piece | Follow @FierceBiotech

@JohnCFierce: GSK's Witty confident the co. will be rewarded for big R&D investment in China. Translation: They won't get stiffed. Article | Follow @JohnCFierce

@RyanMFierce: NCI's cancer informatics group says goodbye to chief after program stalls. News via @bioitworld. Story | Follow @RyanMFierce

@FierceMedDev: Youngstown News, New motion-sensor technology eases debilitating pain of Boardman man. News via @vindicator. Story | Follow @FierceMedDev

> Company 'insiders' nabbed 43% of Verastem's IPO offering. More

> High Ph3 placebo response complicates Lundbeck's case for anti-drinking drug. Article

Medical Device News

> Mouth sensor, iPhone boost quadriplegics' mobility. Item

> Structural heart disease devicemaker lands $250K in seed money. News

> Australia's TGA slammed for device safety oversight. Article

> Families sue Synthes, former execs over deaths in bone cement case. Story

IT News

> Aptiv marries IT and CRO services to tackle adaptive trials market. Story

> NIH backs effort to integrate clinical trials data into EHRs. Article

> Social media jump-starts stalled patient recruitment efforts. Item

And Finally... Merck ($MRK) says it will ask the FDA to approve allergy pills for ragweed and grass reactions as an alternative to traditional immunotherapy. Article